How Much Weight Will You Lose with Wegovy?

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has transformed weight loss treatment for millions of people seeking sustainable results beyond diet and exercise alone. The STEP trials demonstrated that patients using semaglutide lost between 15% and 22% of their starting body weight—a clinically meaningful reduction that reduces disease risk and improves overall health markers. Your individual weight loss journey depends on several factors, including your starting weight, medication adherence, genetic predisposition, and lifestyle choices.

Clinical Trial Results: What the Data Shows

The landmark STEP clinical trials followed over 4,500 patients across multiple sites and measured weight loss over 68 weeks of semaglutide treatment. Patients receiving the highest tolerated dose lost an average of 22.3% of their body weight, compared to 2.6% in the placebo group—a sevenfold difference. At lower doses, weight loss ranged from 15% to 18%, demonstrating a dose-response relationship. These results represent some of the most significant pharmaceutical weight loss outcomes in medical history.

Real-world data from clinical practices shows similar outcomes when patients remain consistent with their treatment plan. Most patients experience noticeable weight loss within the first 4-8 weeks, with continued steady reduction over 3-6 months. The medication works by slowing stomach emptying, increasing fullness signals to your brain, and regulating appetite-control hormones—mechanisms that persist as long as you use the medication.

How Your Genetics Influence Weight Loss Response

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with certain genetic predispositions to GLP-1 sensitivity often experience faster initial weight loss and may require lower doses to achieve their goals. Others may benefit from combination therapy or alternative compounds like tirzepatide, which activates both GLP-1 and GIP receptors. The Precision Peptide Genetic Test maps 49 distinct peptide pathways and 150+ genetic insights, helping you avoid months of trial-and-error dosing.

Factors That Impact Your Individual Weight Loss

Your starting body weight significantly influences total pounds lost—a patient weighing 300 pounds may lose 60-70 pounds, while someone at 200 pounds might lose 30-40 pounds, even though the percentage loss is similar. Calorie intake and physical activity remain important; semaglutide works best when combined with consistent eating habits and moderate movement. Sleep quality, stress levels, underlying metabolic conditions, and medication interactions also shape your results.

Dose escalation matters substantially for weight loss outcomes. Patients who gradually titrate to higher tolerated doses typically lose more weight than those staying at lower doses or stopping too early due to side effects. PlexusDx compounded semaglutide allows personalized dose adjustments—your dose may need to go up, but your price won't change, keeping treatment affordable as your provider optimizes your therapy. Consistency over time matters more than speed; most providers recommend at least 3-6 months before evaluating total weight loss.

Maintaining Results and Long-Term Success

Weight loss with semaglutide is not temporary—clinical data shows sustained reduction as long as the medication is continued. Studies tracking patients beyond the initial 68-week period demonstrate maintained weight loss for years with ongoing therapy. The medication does not produce permanent metabolic changes; stopping treatment typically leads to gradual weight regain, which is why long-term medication management is considered the standard of care for chronic weight management.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose if I weigh 250 pounds?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How long does it take to see weight loss results?

Most patients notice reduced appetite and initial weight changes within 2-4 weeks of starting semaglutide. Measurable weight loss typically becomes obvious between 4-8 weeks, with steady monthly reductions continuing for 3-6 months. Peak weight loss usually occurs around 16-20 weeks of consistent therapy.

What's the cost of semaglutide at PlexusDx?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across all dose levels, with no flat per-compound pricing increases. Treatment is available in all 50 states without insurance, with HSA/FSA eligibility and no membership fees—making consistent access affordable for long-term success.

Can I stop semaglutide once I reach my weight goal?

Stopping semaglutide typically results in gradual weight regain over several months because the medication manages appetite hormones rather than permanently changing metabolism. Most weight management specialists recommend continuing at a maintenance dose long-term to preserve results, similar to blood pressure or cholesterol management.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.